Delivery Order SPE2DB22D3016-SPE2DB25FALG4
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $1,384.44 and a period of performance extending to June 12, 2025. The award is not set aside and was made on a competitive basis. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply MOXIFLOXACIN HCL 400 MG TABLET UD 50S. The contract has a total ceiling value of $3,951.74 and is a Firm Fixed Price Delivery Order, with a performance period through May 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,094.28, is a firm fixed-price delivery order to provide 4,565,047,008 units of the medication Moxifloxacin HCL 400 mg Tablet. The ultimate completion date for this contract is July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,580,380 units of the medication Moxifloxacin HCl 400 mg Tablet 30s, with a ceiling value of $2,921.13. The contract is a Firm Fixed Price Delivery Order, with a period of performance extending through June 18, 2025. The contract is not set aside and is open to full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count packages of the antibiotic medication Moxifloxacin HCL 400 mg tablets, with a total ceiling value of $1,541.01 and a performance period ending on June 24, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,158.61, is for the delivery of 4,564,482,840 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of May 3, 2024. This award is not associated with a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,024.50, is for the delivery of MOXIFLOXACIN HCL 400 MG TABLET UD 50S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with a completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,374,922 units of the medication Moxifloxacin 400 mg/250 ml bag, with a firm fixed price ceiling value of $1,666.22 and a performance period through May 29, 2025. This contract is not set aside and allows for the delivery of both brand-name and generic pharmaceutical...